Downstream targets of IL-6, mainly JAK/STAT, regulate neuroinflammation and affect the survival of neuronal and glial cells, as evidenced by the dysregulation of JAK/STAT pathway in brain disorders, such as brain cancers, ischemia, and Alzheimer’s disease (AD). Here, SOAT1 is linked to brain disorder.